Dabigatran etexilate Terminated Phase 2 Trials for Heart Valve Diseases Prevention

IndicationsStatusPurposePhase
TerminatedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01452347Dabigatran Etexilate in Patients With Mechanical Heart Valves